Savvoula Savvidou

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Semaglutide-Induced Weight Loss Is the Main Determinant for the Improvement of Hepatic Biochemistry and Elastographic Repeated Measurements with FibroScan® in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Semaglutide-Induced Weight Loss Is the Main Determinant for the Improvement of Hepatic Biochemistry and Elastographic Repeated Measurements with FibroScan® in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Metabolic syndrome and related disorders

Published: April 07, 2026

Diagnostic Accuracy of FibroScan-AST (FAST) Score for Identifying Severe Nonalcoholic Steatohepatitis in a Greek Cohort.

Diagnostic Accuracy of FibroScan-AST (FAST) Score for Identifying Severe Nonalcoholic Steatohepatitis in a Greek Cohort.

Journal: Journal of clinical and experimental hepatology

Published: June 05, 2023

Ultrasonographic assessment of diaphragmatic contraction and relaxation properties: correlations of diaphragmatic displacement with oesophageal and transdiaphragmatic pressure.

Ultrasonographic assessment of diaphragmatic contraction and relaxation properties: correlations of diaphragmatic displacement with oesophageal and transdiaphragmatic pressure.

Journal: BMJ open respiratory research

Published: June 03, 2021

Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B.

Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B.

Journal: JHEP reports : innovation in hepatology

Published: February 05, 2021

Reply to Jonkman et al.: Tissue Doppler Imaging of the Diaphragm: A Novel Approach but Too Early for Clinical Implementation?

Reply to Jonkman et al.: Tissue Doppler Imaging of the Diaphragm: A Novel Approach but Too Early for Clinical Implementation?

Journal: American journal of respiratory and critical care medicine

Published: September 22, 2020

Tissue Doppler Imaging of the Diaphragm in Healthy Subjects and Critically Ill Patients.

Tissue Doppler Imaging of the Diaphragm in Healthy Subjects and Critically Ill Patients.

Journal: American journal of respiratory and critical care medicine

Published: July 03, 2020

Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B.

Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B.

Journal: Journal of hepatology

Published: January 25, 2020

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.

Journal: Journal of hepatology

Published: April 24, 2019

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.

Journal: Journal of hepatology

Published: November 28, 2017

The impact of healthcare professionals' personality and religious beliefs on the decisions to forego life sustaining treatments: an observational, multicentre, cross-sectional study in Greek intensive care units.

The impact of healthcare professionals' personality and religious beliefs on the decisions to forego life sustaining treatments: an observational, multicentre, cross-sectional study in Greek intensive care units.

Journal: BMJ open

Published: July 23, 2017

A central venous catheter that revealed a vascular paradox.

A central venous catheter that revealed a vascular paradox.

Journal: Thorax

Published: March 07, 2017

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.

Journal: Hepatology (Baltimore, Md.)

Published: November 08, 2016

Showing 1-12 of 23

Last Updated: 09/26/2026